Support BIDMC’s COVID-19 Recovery Initiatives
As we navigate the greatest challenge in our history, philanthropic support is critically needed. Learn more about our extraordinary COVID-19 efforts and how you can help us. Give Now.
Your Giving Matters
Healthcare Heroes
Support our dedicated staff as they work day and night to ensure extraordinary care for all
Learn More
Research
Give today to the most brilliant minds in medicine who are finding innovative solutions for today’s most pressing global health challenges
Learn More
ICU Campaign
Fund our new inpatient building, which will enhance our critical care capacity with an entire ICU floor
Learn More
More BIDMC COVID-19 News
Kevin Hill, MD (Addiction Psychiatry, BIDMC) and Mia Hazel, MD (Addiction Psychiatry BIDMC), shared data showing those with addictions are eight times more likely than those without to get COVID-19. They have found that increasing the frequency of virtual appointments has been essential for helping patients stay engaged in recovery treatment.
WBUR – March 3, 2021 How The Pandemic Has Made Staying Sober Even More Difficult
Read More
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) spoke to recently emerged data from the Johnson & Johnson trial where researchers looked for signs of infection in 3,000 participants up to 71 days after getting the single-dose vaccine. Risk of infection in that study seemed to fall by about 74 percent.
New York Times – March 3, 2021 Plan to Ditch the Mask After Vaccination? Not So Fast.
Read More
Pharmaceutical giant Merck will help manufacture the newly authorized Johnson & Johnson single-shot COVID-19 vaccine. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) shared that the collaboration could greatly accelerate the rollout of the Johnson & Johnson vaccine at a time when acceleration of the vaccine campaign in the US and throughout the world is needed.
Boston Globe – March 2, 2021 Merck to help rival Johnson & Johnson make COVID-19 vaccine.
Read More#BIDMCSocial
View the latest updates, information, and stories of hope from Beth Israel Deaconess Medical Center and across the Beth Israel Lahey Health system. Like, share and comment!
This Employee Appreciation Day, we'd like to give an extra special THANK YOU to all of our staff at BIDMC. We appreciate all you do every day to help deliver extraordinary care. 💙
Do you want to thank a BIDMC nurse for all they've done over the past year? You can show your gratitude by nominating them for The Boston Globe 's 18th annual "Salute to Nurses." It's a special Sunday issue on May 9, 2021. Submissions are open until March 22. Click the link to make your nomination today! ⤵️
As we enter Women's History Month, Beth Israel Deaconess Medical Center is proud and honored to celebrate the achievements of women from the past, present, and future.
In the midst of a pandemic, we also salute those who have taken the lead to ensure the safety of our patients, their families, and our communities.
Thank you for your hard work and dedication.
As of March 1, 2021, BIDMC is pleased to welcome visitors back to our inpatient facilities. For the most up-to-date visitor policies, please visit our website: bit.ly/39bHwrD
In the latest episode of Beth Israel Lahey Health's COVID Conversations, Mary LaSalvia, MD, Director of Infectious Disease at BIDMC, answers "What are the latest guidelines about wearing a mask?".
bit.ly
Johnson & Johnson’s single-shot COVID-19 vaccine, developed in part at BIDMC, receives unanimous vote of confidence by US FDA vaccine advisory committee.“With a J&J vaccine, we’ll be able to accelerate the vaccine rollout for our country and for the world.”
Dan Barouch, MD, PhD, Director of the Center for Virology and Vaccine Research at BIDMC, spoke to The New York Times about the Johnson & Johnson #COVID19 vaccine awaiting emergency use authorization. nyti.ms/3uwgaoc
New analyses show Johnson & Johnson’s one-dose vaccine works well.
nyti.ms
F.D.A. studies show the shot strongly protects against severe illness and may reduce spread of the virus. But the drugmaker has fallen short of initial production goals.People with substance use disorder have been hit especially hard by COVID-19. Kevin Hill, M.D, M.H.S, Director of the Division of Addiction Psychiatry at #BIDMC authored a Boston Globe Opinion piece on the work his team is doing to help address this problem. bit.ly/2NAXao3
COVID-19 makes it harder to stay sober - The Boston Globe
bit.ly
The stress and worry that came with the pandemic have proved to be a stern test of the coping strategies for those with substance use disorder.Dealing with the uncertainty and isolation of COVID-19 over the past year has been exceptionally challenging for everyone,” notes Dhruv Kazi, MD, MSc, Assistant Director of the Smith Center for Outcomes Research in Cardiology and Director of the Cardiac Critical Care Unit at BIDMC. Read how people who have adopted pets over the past year have gained comfort, companionship, and, in many cases, improved cardiovascular health. bit.ly/3dz26EH #HeartMonth
Pictured: Rosie from BIDMC's Pet Therapy Program
Words of Encouragement
Share a message of encouragement and support for our healthcare heroes
This is a moderated board. Your message will appear once it has been reviewed. Posts may be modified or not included to protect privacy. Thank you for sharing your support!
.
Thank You
We are so grateful for your support during these unprecedented times. Your quick response is funding our efforts to fight the COVID-19 pandemic and giving us the flexibility we need to address this critical situation.
As we continue to provide extraordinary care to our patients, we are overwhelmed by the outpouring of support we have received from the community.
Please watch this message of thanks from Marsha Maurer, DNP, RN, Senior Vice President for Patient Care Services, Cynthia and Robert J. Lepofsky Chief Nursing Officer and Incident Commander for the COVID-19 response at BIDMC.